MedTrace Logo

Hydromorphone for Perioperative Analgesia in Lung Tumor Ablation Parallel Controlled

NCT05848635 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2023-05-08

No results posted yet for this study

Summary

This randomized, parallel controlled, single blind trial is designed to evaluate the efficacy and safety of hydromorphone versus morphine for perioperative analgesia in lung tumor ablation.

Conditions

  • Pulmonary Nodule
  • Ablation

Interventions

DRUG

Hydromorphone Hydrochloride

Drug: Hydromorphone Hydrochloride Hydromorphone hydrochloride injection is used for perioperative lung tumor ablation

DRUG

Morphine hydrochloride

Drug: Morphine Hydrochloride Morphine hydrochloride injection is used for perioperative lung tumor ablation

Sponsors & Collaborators

  • Qianfoshan Hospital

    lead OTHER

Principal Investigators

  • Xin Ye, graduate · head of intervention department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2024-05-01
Completion
2024-05-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05848635 on ClinicalTrials.gov